Showing results (2341-2350 of 2,591) with videos related to

Sort By:
Pageof 260
Molecular Oncology|August 6, 2014
Senescent stroma promotes prostate cancer progression: the role of miR-210Maria Letizia Taddei, Lorenzo Cavallini, Giuseppina Comito, et al.
Molecular Oncology|August 6, 2014
Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysisCheng-Lung Hsu, Jai-Shin Liu, Po-Long Wu, et al.
Molecular Oncology|January 10, 2013
Targeted tumor therapy by epidermal growth factor appended toxin and purified saponin: an evaluation of toxicity and therapeutic potential in syngeneic tumor bearing miceMayank Thakur, Katharina Mergel, Alexander Weng, et al.
Molecular Oncology|January 15, 2013
HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expressionPierre-François Cartron, Christophe Blanquart, Eric Hervouet, et al.
Molecular Oncology|December 12, 2012
Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cellsCinzia Giordano, Donatella Vizza, Salvatore Panza, et al.
Molecular Oncology|January 8, 2013
Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigenAndrew J McCluskey, Andrew J Olive, Michael N Starnbach, et al.
Molecular Oncology|December 11, 2012
Meeting the global demands of epidemiologic transition - the indispensable role of cancer preventionSilvia Franceschi, Christopher P Wild
Molecular Oncology|August 15, 2013
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancersKatharina Grupp, Stella Sanader, Hüseyin Sirma, et al.
Molecular Oncology|September 24, 2013
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapyGwendlyn Kollmorgen, Gerhard Niederfellner, Alexander Lifke, et al.
Molecular Oncology|June 4, 2013
WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cellsChandra Prakash Prasad, Shivendra Kumar Chaurasiya, Lena Axelsson, et al.
Pageof 260